Font Size: a A A
Keyword [relapsed or refractory]
Result: 1 - 20 | Page: 1 of 2
1. Clinical Study On Bortezomib And Thalidomide In The Treatment Of Multiple Myeloma
2. Response To Lower Dose Rituximab Therapy In Childhood And Adult With Relapsed Or Refractory Immune Thrombocytopenia
3. Curative Effect Of Yiqi Yangxue Huoxue Fang For Patients With Idiopathic Thrombocytopenic Purpura Relapsed Or Refractory To Glucocorticoids
4. The Clinical Observation Of Bortezomib Used In Relapsed Or Refractory Hematologic Malignancy
5. Homoharringtonine And Low-Dose Cytosine Arabinoside Combined With G-CSF Or GM-CSF Administered In Patients With Advanced Myelodysplastic Syndromes, Relapsed Or Refractory Acute Myeloid Leukemia(AML) And Geriatric AML
6. Bortezomid In Combination With Chemotherapy In The Treatment Of Relapsed Or Refractory Multiple Myeloma
7. The Effects Of Bortezomib And Dexamethasone In The Treatment Of Relapsed Or Refractory Multiple Myeloma
8. The Clinical Research On The Efficacy Of GDP Regimen On Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma
9. United Ubenimex Thalidomide Treatment Of Relapsed Or Refractory Multiple Myeloma Cancer
10. Primary Investigation Of ProMACE-CytaBOM Modified Regimen In Treating Relapsed Or Refractory Aggressive NHL
11. The Analysis Of GEMOX Regimen On Relapsed Or Refractory Non-Hodgkin’s Lymphoma
12. Clinical Analysis Of NO And GEMOX Regimen In The Treatment Of Relapsed Or Refractory Non-Hodgkin’s Lymphoma
13. The Efficacy And Safety Of Hyper-CVAD/MA Regimen In The Treatment Of Relapsed Or Refractory Diffuse Large B-cell Lymphoma
14. Retrospective Analysis On The Efficacy Of Bortezomib-based Regimens In Multiple Myeloma
15. The Present And Updates In Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia
16. A Comparative Study Between Bifunctional Alkylating And General Regimens In Relapsed Or Refractory Indolent Lymphoma, And The Exploration Of Prognostic Factors
17. Carfilzomib For The Treatment Of Multiple Myeloma:A Systematic Review
18. Possible Factors On Efficacy And Safety Of CAR-T Therapy In Relapsed Or Refractory Lymphomas
19. Evaluating The Value Of Daratumumab For The Treatment Of Patients With Relapsed Or Refractory Multiple Myeloma
20. The Clinical Observations Of Lenalidomine Plus Dexamethasone For Relapsed And Refractory Multiple Myeloma
  <<First  <Prev  Next>  Last>>  Jump to